Health and Science #educratsweb
HOME | LATEST JOBS | JOBS | CONTENTS | STUDY MATERIAL | CAREER | NEWS | BOOK | VIDEO | PRACTICE SET REGISTER | LOGIN | CONTACT US

Health and Science

https://www.cnbc.com/id/10000108/device/rss/rss.html 👁 1403

Health insurer stocks fall after Trump administration seeks overturn of Affordable Care Act


The biggest decliners were Molina Health, which fell nearly 10 percent during Tuesday's session, and Centene which fell nearly 5 percent.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/26/health-insurer-stock-fall-after-trump-administration-seeks-aca-overturn.html

OxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid case


The case against Purdue and other manufacturers was scheduled to go to trial in May. Accusations against the Stamford, Connecticut-based company included downplaying the addiction risk of opioids while overstating the benefits.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/26/purdue-pharma-and-sackler-family-agree-to-pay-270-million-in-opioid-case.html

White House and Pelosi's staff in early talks about legislation to cut high drug costs


The Trump administration is in talks with House Speaker Nancy Pelosi about legislation to lower prescription drug costs, a White House official says.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/26/trump-and-pelosi-teams-in-early-talks-about-drug-price-legislation.html

Shares of Canadian pot company Cronos slide after revenue disappoints


Shares of Canadian pot company Cronos slid 5 percent Tuesday after the company reports disappointing fourth-quarter revenue.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/26/shares-of-canadian-pot-company-cronos-slide-after-revenue-disappoints.html

White House touts progress in opioid crisis, but health researchers are skeptical


Health researchers say there's little evidence to show that recent progress is a result of the White House's efforts.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/26/white-house-touts-progress-in-opioid-crisis-but-some-are-skeptical.html

OxyContin maker Purdue Pharma reaches opioid settlement with Oklahoma attorney general: Source


OxyContin's maker has agreed to settle a lawsuit by the state of Oklahoma accusing it of helping igniting the nationwide opioid crisis, a source says.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/26/purdue-pharma-reaches-opioid-settlement-with-oklahoma-attorney-general.html

Poor mental health shortens life expectancy almost as much as diabetes and smoking


Diabetes and smoking had the strongest correlation to life expectancy, the study finds.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/25/mental-health-as-bad-for-life-expectancy-as-smoking-diabetes-report.html

Apple could combine its expertise in health and fintech to get into medical billing, experts say


Some experts in the space see a big opportunity for Apple to help consumers pay their medical bills, which is a notoriously challenging process.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/25/apple-could-combine-health-and-fintech-to-get-into-medical-billing.html

Health organizations call for taxes and limits marketing sugary soft drinks to children


For the first time the American Academy of Pediatrics and the American Heart Association endorsed enforcing taxes on sodas, among other precautions, in an effort to reduce children's consumption of sugary drinks.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/25/health-groups-call-for-taxes-limits-marketing-soft-drinks-to-kids.html

FDA approves new device for treating patients with chronic heart failure


The Food and Drug Administration approved a breakthrough medical device last week for patients suffering from chronic, hard-to-treat heart failure.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/25/fda-approves-new-device-for-patients-with-chronic-heart-failure.html

Bayer, J&J settle blood thinner Xarelto litigation for $775 million


Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/25/bayer-jj-settle-blood-thinner-xarelto-litigation-for-775-million.html

Eli Lilly sheds light on confidential pricing, discloses charges for popular diabetes drug Humalog


The 'net price' for Eli Lilly's insulin fell to $135 a patient a month in 2018 from $147 in 2014, the company says.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/25/eli-lilly-discloses-pricing-data-for-its-popular-insulin-humalog.html

Biogen announces $5 billion buyback days after shelving Alzheimer's trials


Biogen said on Monday it would buy back shares worth $5 billion, days after its stock slumped on the drugmaker's announcement to end two Alzheimer's disease trials.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/25/biogen-announces-5-billion-buyback-days-after-shelving-alzheimers-trials.html

CBD is booming. But US farmers struggle to keep up with demand for industrial hemp


The nascent CBD industry is trying to work through the kinks at the same time demand is ramping up, leaving producers frustrated and consumers with unreliable products.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/23/cbd-is-booming-but-us-farmers-struggle-to-keep-up-with-demand.html

Silicon Valley techies are turning to a cheap diabetes drug to help them live longer


Doctors feel that taking metformin is mostly safe, but cautioned about the lack of clinical studies.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/23/metformin-for-cancer-prevention-longevity-popular-in-silicon-valley.html

Failed Alzheimer's trial leaves families and patients heartbroken. Medical community reels


Biogen and Eisai lost billions of dollars in market value after halting two late-stage trials of a promising experimental Alzheimer's drug.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/23/failed-alzheimers-trial-leaves-families-and-patients-heartbroken.html

How a premature ejaculation drug sparked a $150 million legal battle over trade secrets


The maker of the premature ejaculation drug Promescent is suing consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade secrets.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/23/how-sex-drug-promescent-sparked-a-150-million-legal-battle.html

Humana turns to game theory for new Medicare pricing as insurers juggle Trump rebate uncertainty


The game theory comes in with the timing of when new rules might be adopted. Executives note the deadline for filing 2020 plans is in early June.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/22/humana-turns-to-game-theory-for-new-medicare-price-structure.html

'Game of Thrones' star Emilia Clarke reveals she suffered 2 life-threatening brain aneurysms


The news comes as the actor launched "SameYou", a charity aiming to offer treatment to those recovering from stroke and brain injury.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/22/actor-emilia-clarke-opens-up-aneurysms-and-recovery.html

Biogen stock plunge shows 'investment model in drug development is all wrong,' says former Aetna CEO


Former Aetna Chairman and CEO Mark Bertolini says investors currently are trading "on a basis that says, 'does this drug work today? Did this trial pass today?''"

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/22/biogen-stock-fall-shows-drug-investment-model-is-wrong-ex-aetna-ceo.html

Snap to drug advertisers: We're the friendlier social network


To win big pharmaceutical advertisers, Snap is positioning itself as a friendlier social network than Facebook and Twitter.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/22/snap-pitch-to-big-pharma-advertisers-friendlier-social-network.html

Eisai starts trials for a second Alzheimer's drug a day after Biogen failure wiped $18B off its value


Eisai said it has begun phase 3 clinical trials of Alzheimer's treatment, a day after the Japanese drugmaker and U.S. partner Biogen scrapped trials for its own Alzheimer's drug.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/22/eisai-starts-phase-3-trials-for-second-alzheimers-drug-after-firsts-failure.html

Sugary drinks may help fuel colon cancer tumors, study in mice suggests


The study shows how sugar drives tumor growth, possibly explaining a surge in early colon cancer diagnoses in young adults.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/21/sugary-drinks-may-help-fuel-colon-cancer-tumors-study-in-mice-suggests.html

Rite Aid shareholders approve reverse stock split


Rite Aid shareholders have approved the company's reverse stock split, the company announced Thursday, a move aimed at keeping the drugstore chain's shares trading on New York Stock Exchange.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/21/rite-aid-shareholders-approve-reverse-stock-split.html

CVS heard from its customers who use CBD, will 'walk slowly' in the space, CEO Larry Merlo says


CVS has started selling CBD, short for cannabidiol products, in eight states. CEO Larry Merlo said CVS will "walk slowly."

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/21/cvs-starts-selling-cbd-products-in-some-states-after-hearing-from-customers.html

Cramer Remix: Forget the stocks caught in the trade war crossfire


Jim Cramer reveals why Nike is an ideal investment that can do well with or without a trade deal.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/20/cramer-remix-forget-the-stocks-caught-in-the-trade-war-crossfire.html

CVS has started selling cannabis-based products in 8 states


The pharmacy chain said the products include topicals such as creams, sprays, roll-ons, lotions and salves.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/20/cvs-has-started-selling-cannabis-based-products-in-8-states.html

Harvard researchers say certain ADHD medications may increase risk of psychosis


Certain medications commonly used to treat ADHD in teens and young adults may increase their risk of psychosis, according to researchers at Harvard Medical School and McLean Hospital.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/20/harvard-researchers-say-certain-adhd-drugs-may-up-risk-of-psychosis.html

Start-up behind erectile dysfunction website Roman launches health service for women


Ro, the men's health start-up known for straight-to-your-door erectile dysfunction medication, is launching a new service targeting women.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/20/erectile-dysfunction-website-roman-launches-health-service-for-women.html

Pfizer buys stake in French gene therapy firm Vivet


Pfizer Inc said on Wednesday it has acquired a 15 percent stake in Vivet Therapeutics, and has an exclusive option to fully acquire the privately held French company that develops gene therapies for liver disorders.

Click here to Read full Details Sources @ https://www.cnbc.com/2019/03/20/pfizer-buys-stake-in-french-gene-therapy-firm-vivet.html

SHARE THIS


Subscribe via Email


Explore Jobs/Opportunities
West Bengal Jobs / Opportunities / Career
Sarkari Naukri Jobs / Opportunities / Career
Assam Jobs / Opportunities / Career
Explore Articles / Stories
Education
Government Schemes
News
Career
Admit Card
Study Material
Bihar
State Government Schemes
Technology
DATA
Public Utility Forms
Travel
Sample Question Paper
Exam Result
Employment News
Scholorship
Business
Astrology
Syllabus
Festival
Explore more
Main Page
Register / Login
Like our Facebook Page
Follow on Twitter
Subscrive Our Newsletter Via Nuzzle
Get Updates Via Rss Feed
Sarkari Niyukti
Free Online Practice Set
Latest Jobs
Feed contents
Useful Links
Photo
Video
Post Jobs
Post Contents
Supremedeal : India Business Directory
Find IFSC Code
Find Post Office / Pincode
Contact us
Best Deal

Disclaimer: we only provide job information. we are not associated with any job website. Although we take extreme care for accuracy of the information provided, but you must check the authenticity of the website before applying for the job. We are not responsible for your operation , once you leave our website and apply thereafter. Please recheck the genuineness of the job website from yourself also.

Copyright © 2018. Website template by WebThemez.com